Accurate identification and isolation of CSCs are challenging due to their rarity and the lack of universally unique markers across all cancer types. Researchers are developing advanced techniques, including flow cytometry based on specific cell surface markers (like CD44 or CD133) and functional assays such as in vitro sphere formation. The ability to precisely quantify the CSC popul... https://www.beatcancerfoundation.org/